查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611088

乳糜泻治疗市场规模、份额、趋势分析报告：按治疗、给药途径、通路、地区和细分市场预测，2024-2030

Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten-free Diet), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

乳糜泻治疗市场趋势

2023年，全球乳糜泻治疗市场规模为5.825亿美元，预计2024年至2030年复合年增长率为11.8%。这种增长是由于确诊病例的盛行率不断增加以及对有效治疗和诊断方法的需求不断增加。此外，大众对乳糜泻症状和早期诊断重要性的认识不断提高，导致更多的人寻求医疗协助。此外，不断扩大的无麸质食品行业透过提供多种饮食选择来支持市场。诊断技术的进步和新治疗方法的持续研究透过改善疾病检测和管理进一步促进市场成长。

各国政府正在实施各种倡议，以提高对乳糜泻的认识并改善获得诊断和治疗的机会。例如，一些国家製定了针对高风险族群的筛检计画。此外，乳糜泻的 POCT（就地检验）由于其快速诊断能力，近年来已获得认可。这样可以及时诊断和早期治疗，从而避免对患者带来进一步的严重风险。随着人们对该疾病的认识不断提高，主要企业正在投资药品和无麸质产品，以改善患者的健康和整体结果。无麸质产品的好处导致了无麸质产品的采用和利用。

此外，由于抗发炎药物和治疗性疫苗的开发、医疗保健成本的上升以及持续的医学研究，乳糜泻治疗市场预计将在全球范围内扩大，这进一步促进了市场的成长。由于一些国家治疗产品的采用和糖尿病患者数量的增加，预计该市场将快速成长。此外，各医疗机构所进行的研发活动以及创新治疗方法和实践的支出正在扩大乳糜泻治疗市场扩张的机会。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章乳糜泻治疗市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 乳糜泻治疗市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 乳糜泻治疗市场：依治疗方法估计与趋势分析

  • 细分仪表板
  • 乳糜泻治疗市场：2023 年和 2030 年治疗变化分析
  • 维生素和矿物质
  • 无麸质饮食
  • 药物治疗

第五章乳糜泻治疗市场：依给药途径估计与趋势分析

  • 细分仪表板
  • 乳糜泻治疗市场：2023 年及 2030 年给药途径变异分析
  • 口服
  • 胃肠外的

第六章乳糜泻治疗市场：按分销管道估计和趋势分析

  • 细分仪表板
  • 乳糜泻治疗市场：2023 年和 2030 年通路变化分析
  • 医院
  • 研究中心
  • 其他的

第七章乳糜泻治疗市场：区域估计和趋势分析

  • 2023 年及 2030 年乳糜泻治疗市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC.
    • Glenmark Life Sciences Limited
    • Takeda Pharmaceutical Company Limited.
    • Hikma Pharmaceuticals PLC
    • Viatris Inc.
    • Zydus Pharmaceuticals, Inc.
    • Novartis AG
    • BioLineRx Ltd.
Product Code: GVR-4-68040-488-7

Celiac Disease Treatment Market Trends:

The global celiac disease treatment market size was valued at USD 582.5 million in 2023 and is projected to grow at a CAGR of 11.8% from 2024 to 2030. This growth is attributed to the increasing prevalence of diagnosed cases, which has heightened the demand for effective treatments and diagnostic methods. In addition, growing public awareness regarding celiac disease symptoms and the importance of early diagnosis has led to more individuals seeking medical attention. Furthermore, the expanding gluten-free food industry supports the market by providing diverse dietary options. Advances in diagnostic technologies and ongoing research into new treatment modalities further contribute to market growth by improving the detection and management of the disease.

Governments of many nations are implementing various initiatives to create awareness about celiac disease and uplift the accessibility to diagnostics and treatment for every individual. For instance, some countries have conducted screening programs specifically targeting high-risk populations. In addition, point-of-care testing (POCT) for celiac disease has gained acceptance in the past few years because of its quick diagnostic proficiencies. This allows for timely diagnosis and enables early treatment, avoiding further severe risks to the patient. Along with increased disease awareness, key companies invest in drugs and gluten-free products to enhance patients' health and overall outcomes. The benefits of gluten-free products have led to the adoption and utilization of gluten-free items.

Furthermore, the market for celiac disease treatment is anticipated to expand worldwide, fueled by the development of anti-inflammatory drugs and therapeutic vaccines, rising healthcare expenditure, and continuous medical research, which further contribute to market growth. Adopting therapeutic products and rising diabetes cases in several countries is expected to surge market growth. In addition, R&D activities and expenditure for innovative treatment alternatives and practices executed by various healthcare organizations have opened more opportunities for market expansion of celiac disease treatment.

Global Celiac Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global celiac disease treatment market report based on treatment, route of administration, distribution channel, and region:

  • Treatment Outlook (Revenue, USD Million, 2018 - 2030)
  • Vitamins & Minerals
  • Gluten-free Diet
  • Medical Therapies
    • Infliximab
    • Larazotide Acetate
    • Azathioprine
    • Budesonide
    • Others
  • Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
  • Oral
  • Parenteral
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Research Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Celiac Disease Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Celiac Disease Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Celiac Disease Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Vitamins and Minerals
    • 4.3.1. Vitamins and Minerals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Gluten-free Diet
    • 4.4.1. Gluten-free Diet Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Medical Therapies
    • 4.5.1. Medical Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1. Infliximab
        • 4.5.1.1.1. Infliximab Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2. Larazotide Acetate
        • 4.5.1.2.1. Larazotide Acetate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.3. Azathioprine
        • 4.5.1.3.1. Azathioprine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.4. Budesonide
        • 4.5.1.4.1. Budesonide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.5. Others
        • 4.5.1.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Celiac Disease Treatment Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Celiac Disease Treatment Market: Route of Distribution Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Oral
    • 5.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Parenteral
    • 5.4.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Celiac Disease Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Celiac Disease Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospital
    • 6.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Research Centers
    • 6.4.1. Research Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Celiac Disease Treatment Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Celiac Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Teva Pharmaceutical Industries Ltd.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Amgen Inc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Amneal Pharmaceuticals LLC.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Glenmark Life Sciences Limited
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Takeda Pharmaceutical Company Limited.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Hikma Pharmaceuticals PLC
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Viatris Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Zydus Pharmaceuticals, Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Novartis AG
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. BioLineRx Ltd.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
  • Table 4 North America Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 5 North America Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 North America Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 U.S. Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 8 U.S. Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 U.S. Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 Canada Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 11 Canada Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 Canada Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 14 Mexico Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Mexico Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Europe Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 18 Europe Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 Europe Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 UK Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 21 UK Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 UK Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 24 Germany Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Germany Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 France Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 27 France Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 France Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Spain Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 30 Spain Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Spain Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 33 Italy Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Italy Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Denmark Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 36 Denmark Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 Denmark Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Sweden Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 39 Sweden Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Sweden Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Norway Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 42 Norway Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Norway Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Japan Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 49 Japan Celiac Disease Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 50 Japan Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 52 China Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 China Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 India Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 55 India Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 India Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 South Korea Celiac Disease Market, By Treatment 2018 - 2030 (USD Million)
  • Table 58 South Korea Celiac Disease Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 59 South Korea Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Australia Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 61 Australia Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 Australia Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Thailand Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 64 Thailand Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Thailand Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Latin America Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 68 Latin America Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 Latin America Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Brazil Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 71 Brazil Celiac Disease Market, By Route of Administration 2018 - 2030 (USD Million)
  • Table 72 Brazil Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Argentina Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 74 Argentina Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 Argentina Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa Celiac Disease Market, By Country, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 South Africa Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 81 South Africa Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 South Africa Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 UAE Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 87 UAE Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 UAE Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Celiac Disease Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Celiac Disease Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Celiac Disease Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research approaches
  • Fig. 2 Value chain-based sizing & forecasting
  • Fig. 3 Market formulation & validation
  • Fig. 4 Celiac Disease market segmentation
  • Fig. 5 Market driver analysis (current & future impact)
  • Fig. 6 Market restraint analysis (current & future impact)
  • Fig. 7 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 8 Porter's five forces analysis
  • Fig. 9 Celiac Disease market: Treatment outlook and key takeaways
  • Fig. 10 Celiac Disease market: Treatment movement analysis
  • Fig. 11 Vitamins & Minerals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 12 Gluten-free Diet market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Medical Therapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Infliximab market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Larazotide Acetate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Azathioprine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Budesonide market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Celiac Disease market: Route of administration outlook and key takeaways
  • Fig. 20 Celiac Disease market: Route of administration movement analysis
  • Fig. 21 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Celiac Disease market: Distribution channel outlook and key takeaways
  • Fig. 24 Celiac Disease market: Distribution channel movement analysis
  • Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Research Centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 North America Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Japan Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 China Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Australia Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 MEA Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Celiac Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 List of key emerging company's/disruptors/innovators